Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07501689 · ClinicalTrials.gov registry record · NA
Using Middle School Science Teachers to Address Cancer Health Disparities
A NA study, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,812
- Enrollment target
NCT07501689: Recruiting NA study, sponsored by Weill Medical College of Cornell University.
NCT07501689 is a NA study that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 1,812 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07501689, a NA study, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,812 participants
- Enrollment target
Study Summary
The CARES4You study is testing a middle school science curriculum designed to teach students about cancer risk and prevention. The lessons are taught by regular science teachers during class time and are aligned with national science education standards. The curriculum includes six units (14 lessons) that help students learn about cancer, understand how lifestyle and environmental factors influence risk, and think about ways to make healthy choices. The study will take place in 10 public middle schools in New York City. Some schools will begin using the CARES4You curriculum right away, while others will continue with their usual science lessons and receive the program later. Researchers will compare the two groups of schools. The main goal of the study is to see whether the curriculum increases students' intentions to engage in healthy behaviors that may reduce cancer risk. The study will also examine whether students talk more with their caregivers about cancer risk and prevention after participating in the program. Caregivers may also report on some health behaviors in the household. If the program is effective, CARES4You could provide schools with a practical and sustainable way to teach cancer prevention and promote healthy behaviors among adolescents and their families.
Primary Outcome
Intent to engage in health-promoting behaviors will be assessed by an adapted nine-item instrument. The response scale for each question item ranges from 0 (does not apply to me) to 3 (very likely) with a sum score ranging from 0 to 27. Higher scores represent a greater intention to follow health-promoting behaviors.
Interventions
- BEHAVIORAL CARES4You Curriculum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,812 participants |
| Start Date | 2026-01-29 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT07501689 shows while recruiting
NCT07501689 is an interventional study that assigns participants to a tested intervention. Its 1,812 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% higher).
The record links to 0 conditions, and to 1 intervention - of which CARES4You Curriculum is the first listed.
NCT07501689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07501689 about?
NCT07501689 is a clinical study titled "Using Middle School Science Teachers to Address Cancer Health Disparities". The CARES4You study is testing a middle school science curriculum designed to teach students about cancer risk and prevention. The lessons are taught by regular science teachers during class time and are aligned with national science education standards. The curriculum includes six units (14 lessons...
What is the current status of trial NCT07501689?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,812 participants. The study started on 2026-01-29. Estimated completion is 2028-06-30.
What interventions are being tested in trial NCT07501689?
The interventions under investigation include: CARES4You Curriculum (BEHAVIORAL).
Who is sponsoring clinical trial NCT07501689?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07501689's enrollment target sits among peer trials
1,812 57th of 2000 higher than 1,944 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
- NCT03630055 · 1,800 participants · Phase 3
Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion
- NCT04475640 · 1,800 participants · NA
Cancer Genetic Testing in Ethnic Populations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI